Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Contin-Bordes C"" wg kryterium: Autor


Wyświetlanie 1-65 z 65
Tytuł :
Interaction of Mycoplasma hominis PG21 with human dendritic cells: IL-23-inducing mycoplasmal lipoproteins and inflammasome activation of the cell
Autorzy :
Goret, J.
Beven, Laure
Faustin, B.
Contin-Bordes, C.
Le Roy, C.
Claverol, S.
Renaudin, H.
Bebear, Cécile
PEREYRE, Sabine
Pokaż więcej
Temat :
Mycoplasma hominis
human dendritic cells
lipoproteins
lipopeptide
inflammasome
PCR array
caspase
IL-1β
IL-23
interaction
innate response
pathogenic bacteria
bactérie pathogène
mollicute
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Źródło :
Journal of Bacteriology, American Society for Microbiology, 2017, 199 (15), pp.e00213-17. ⟨10.1128/JB.00213-17⟩
Tytuł :
Recherche systématique d’anticorps anti-SSA 52 et 60 en l’absence d’anticorps antinucléaires : données épidémiologiques et intérêt diagnostique. Quand les rechercher et quelle valeur en pratique courante ?
Autorzy :
Saunier, A.
Contin-Bordes, C.
Ralazamahaleo, M.
Richez, C.
Morlat, P.
Duffau, P.
De Ledinghen, V.
Doutre, M.S.
Blanco, P.
Pellegrin, J.L.
Jean-François, V.
Estibaliz, L.
Pokaż więcej
Źródło :
Revue de Médecine Interne. Jun2015 Supplement 1, Vol. 36, pA65-A66. 1p.
Czasopismo naukowe
Tytuł :
TGFβ promotes low IL10-producing ILC2 with profibrotic ability involved in skin fibrosis in systemic sclerosis.
Autorzy :
Laurent P; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
Allard B; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
Manicki P; Rheumatology Department, CHU de Bordeaux, Bordeaux, France.
Jolivel V; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
Levionnois E; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
Jeljeli M; Immunology Department, CHU Cochin Hospital, University of Paris Descartes Faculty of Medicine Paris Center, Paris, France.
Henrot P; Rheumatology Department, CHU de Bordeaux, Bordeaux, France.
Izotte J; Animal Facility A2, University of Bordeaux, Talence, France.
Leleu D; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
Groppi A; Centre de Bioinformatique de Bordeaux (CBiB), University of Bordeaux, Talence, France.; IBGC, CNRS, UMR 5095, University of Bordeaux, Talence, France.
Seneschal J; Dermatology Department, CHU de Bordeaux, Bordeaux, France.; INSERM U1035, University of Bordeaux, Talence, France.
Constans J; Vascular Medicine Department, CHU de Bordeaux, Bordeaux, France.
Chizzolini C; Immunology and Allergy, University of Geneva, Geneva, Switzerland.
Richez C; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.; Rheumatology Department, CHU de Bordeaux, Bordeaux, France.
Duffau P; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.; Internal Medicine, CHU de Bordeaux, Bordeaux, France.
Lazaro E; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.; Internal Medicine, CHU de Bordeaux, Bordeaux, France.
Forcade E; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.; Hematology, CHU de Bordeaux, Bordeaux, France.
Schaeverbeke T; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.; Rheumatology Department, CHU de Bordeaux, Bordeaux, France.
Pradeu T; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.
Batteux F; Immunology Department, CHU Cochin Hospital, University of Paris Descartes Faculty of Medicine Paris Center, Paris, France.
Blanco P; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.; Immunology department, CHU de Bordeaux, Bordeaux, France.
Contin-Bordes C; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France.; Immunology department, CHU de Bordeaux, Bordeaux, France.
Truchetet ME; ImmunoConcEpt, CNRS, UMR 5164, University of Bordeaux, Talence, France .; Rheumatology Department, CHU de Bordeaux, Bordeaux, France.
Pokaż więcej
Źródło :
Annals of the rheumatic diseases [Ann Rheum Dis] 2021 Jul 20. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis.
Autorzy :
Scherlinger M; Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France.; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.
Guillotin V; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.; Department of Internal Medicine, Saint André, Bordeaux University Hospital, 33076 Bordeaux, France.
Douchet I; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.
Vacher P; INSERM U1218, 33076 Bordeaux, France.
Boizard-Moracchini A; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.
Guegan JP; Explicyte, 229 Cours de l'Argonne, 33000 Bordeaux, France.
Garreau A; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.
Merillon N; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.
Vermorel A; Nephrology Department, Bordeaux University Hospital, 33076 Bordeaux, France.
Ribeiro E; Department of Internal Medicine, Saint André, Bordeaux University Hospital, 33076 Bordeaux, France.
Machelart I; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, 33604, Pessac, France.
Lazaro E; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, 33604, Pessac, France.
Couzi L; Nephrology Department, Bordeaux University Hospital, 33076 Bordeaux, France.
Duffau P; Department of Internal Medicine, Saint André, Bordeaux University Hospital, 33076 Bordeaux, France.
Barnetche T; Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France.; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.
Pellegrin JL; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, 33604, Pessac, France.
Viallard JF; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, 33604, Pessac, France.
Saleh M; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.
Schaeverbeke T; Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France.; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.
Legembre P; Contrôle de la Réponse Immune B et lymphoproliférations, CRIBL, UMR CNRS 7276, INSERM 1262, Limoges, France.
Truchetet ME; Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France.; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.
Dumortier H; CNRS, UPR 3572 I2CT, IBMC, 67000 Strasbourg, France.
Contin-Bordes C; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.; Department of Immunology and Immunogenetics, Bordeaux University Hospital, 33076 Bordeaux, France.
Sisirak V; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.
Richez C; Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France. .; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.
Blanco P; Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France. .; UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.; Department of Immunology and Immunogenetics, Bordeaux University Hospital, 33076 Bordeaux, France.
Pokaż więcej
Źródło :
Science translational medicine [Sci Transl Med] 2021 Jun 30; Vol. 13 (600).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Lupus Erythematosus, Systemic*
T-Lymphocytes, Regulatory*
Animals ; Humans ; Mice ; Selectins ; Transforming Growth Factor beta
Czasopismo naukowe
Tytuł :
Cross-reactive anti-CENP-A autoantibodies induce analytic interference in anti-TIF1γ detection using line-dot immunoassay.
Autorzy :
Gensous N; Immunology Department, Bordeaux University Hospital, Bordeaux, F-33000, France.; Internal Medicine Department, Bordeaux University Hospital, Bordeaux, F-33000, France.; University Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, F-33000, France.
Zanardo L; Immunology Department, Bordeaux University Hospital, Bordeaux, F-33000, France.
Martinroche G; Immunology Department, Bordeaux University Hospital, Bordeaux, F-33000, France.
Victor J; Internal Medicine Department, Bordeaux University Hospital, Bordeaux, F-33000, France.
Fabien N; Department of Immunology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France.
Duffau P; Internal Medicine Department, Bordeaux University Hospital, Bordeaux, F-33000, France.; University Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, F-33000, France.
Contin-Bordes C; Immunology Department, Bordeaux University Hospital, Bordeaux, F-33000, France.; University Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, F-33000, France.
Pokaż więcej
Źródło :
Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2021 May 22. Date of Electronic Publication: 2021 May 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: Lessons from a prospective multicentric study.
Autorzy :
Passot C; EA7501, University of Tours, France.; Laboratory of Pharmacology-Toxicology, CHRU de Tours, France.; Integrated Center for Oncology, Angers, France.
Sberro-Soussan R; Service de Néphrologie et Transplantation Adulte, Hôpital Necker-Enfants Malades, Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France.
Bertrand D; Department of Nephrology and Transplantation Centre, Rouen, France.
Caillard S; Nephrology and Transplant Department, Strasbourg University Hospital, Strasbourg, France.
Schvartz B; Nephrology and Transplant Department, Reims, France.
Domenger C; Nephrology and Transplant Department, Grenoble, France.
Contin-Bordes C; Laboratory of Immunology and Immunogenetic, Bordeaux, France.
Paintaud G; EA7501, University of Tours, France.; Laboratory of Pharmacology-Toxicology, CHRU de Tours, France.
Halimi JM; EA4245 Transplant Immunology and Inflammation, Université de Tours, Tours, France.; Service de Néphrologie-Hypertension artérielle, Dialyses, Transplantation rénale, CHRU Tours, France.
Ternant D; EA7501, University of Tours, France.; Laboratory of Pharmacology-Toxicology, CHRU de Tours, France.
Gatault P; EA4245 Transplant Immunology and Inflammation, Université de Tours, Tours, France.; Service de Néphrologie-Hypertension artérielle, Dialyses, Transplantation rénale, CHRU Tours, France.
Pokaż więcej
Źródło :
British journal of clinical pharmacology [Br J Clin Pharmacol] 2021 May; Vol. 87 (5), pp. 2236-2246. Date of Electronic Publication: 2020 Dec 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study.
Autorzy :
Monet-Didailler C; Service de Pédiatrie, Unité de Néphrologie, Centre de référence Maladies Rénales Rares du Sud-ouest, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Chevallier A; Service de Pédiatrie, Unité de Néphrologie, Centre de référence Maladies Rénales Rares du Sud-ouest, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Godron-Dubrasquet A; Service de Pédiatrie, Unité de Néphrologie, Centre de référence Maladies Rénales Rares du Sud-ouest, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Allard L; Service de Pédiatrie, Unité de Néphrologie, Centre de référence Maladies Rénales Rares du Sud-ouest, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Delmas Y; Service de Néphrologie, Centre de référence Maladies Rénales Rares du Sud-ouest, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Contin-Bordes C; Laboratoire d'Immunologie et Immunogénétique, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Brissaud O; Service de Réanimation Pédiatrique, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Llanas B; Service de Pédiatrie, Unité de Néphrologie, Centre de référence Maladies Rénales Rares du Sud-ouest, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
Harambat J; Service de Pédiatrie, Unité de Néphrologie, Centre de référence Maladies Rénales Rares du Sud-ouest, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.; Université de Bordeaux, Inserm, Bordeaux Population Health Research Center, UMR 1219, Bordeaux, France.
Pokaż więcej
Źródło :
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2020 Dec 04; Vol. 35 (12), pp. 2147-2153.
Typ publikacji :
Journal Article
MeSH Terms :
Antibodies, Monoclonal, Humanized/*therapeutic use
Complement Inactivating Agents/*therapeutic use
Escherichia coli Infections/*complications
Hemolytic-Uremic Syndrome/*drug therapy
Shiga Toxin/*toxicity
Shiga-Toxigenic Escherichia coli/*pathogenicity
Case-Control Studies ; Child ; Child, Preschool ; Escherichia coli Infections/chemically induced ; Escherichia coli Infections/microbiology ; Female ; Hemolytic-Uremic Syndrome/microbiology ; Hemolytic-Uremic Syndrome/pathology ; Humans ; Infant ; Male ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Elevated Circulatory Levels of Microparticles Are Associated to Lung Fibrosis and Vasculopathy During Systemic Sclerosis.
Autorzy :
Leleu D; University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.; Immunology and Immunogenetic Department, Bordeaux University Hospital, Bordeaux, France.
Levionnois E; University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.
Laurent P; University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.
Lazaro E; University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.; Internal Medicine Department, Bordeaux University Hospital, Bordeaux, France.; Centre national de reference des maladies auto-immunes systémiques rares de l'Est et du Sud-Ouest (RESO), Bordeaux, France.
Richez C; University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.; Centre national de reference des maladies auto-immunes systémiques rares de l'Est et du Sud-Ouest (RESO), Bordeaux, France.; Rheumatology Department, Bordeaux University Hospital, Bordeaux, France.
Duffau P; University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.; Internal Medicine Department, Bordeaux University Hospital, Bordeaux, France.
Blanco P; University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.; Immunology and Immunogenetic Department, Bordeaux University Hospital, Bordeaux, France.
Sisirak V; University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.
Contin-Bordes C; University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.; Immunology and Immunogenetic Department, Bordeaux University Hospital, Bordeaux, France.
Truchetet ME; University of Bordeaux, CNRS, ImmunoConcEpT, UMR 5164, Bordeaux, France.; Centre national de reference des maladies auto-immunes systémiques rares de l'Est et du Sud-Ouest (RESO), Bordeaux, France.; Rheumatology Department, Bordeaux University Hospital, Bordeaux, France.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2020 Oct 23; Vol. 11, pp. 532177. Date of Electronic Publication: 2020 Oct 23 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell-Derived Microparticles/*immunology
Pulmonary Fibrosis/*immunology
Scleroderma, Systemic/*immunology
Vascular Diseases/*immunology
Aged ; Cell-Derived Microparticles/metabolism ; Cell-Derived Microparticles/pathology ; Extracellular Matrix Proteins/biosynthesis ; Extracellular Matrix Proteins/immunology ; Female ; Fibroblasts/immunology ; Fibroblasts/metabolism ; Fibroblasts/pathology ; Flow Cytometry ; Gene Expression Regulation/immunology ; Humans ; Male ; Middle Aged ; Pulmonary Fibrosis/blood ; Pulmonary Fibrosis/pathology ; Scleroderma, Systemic/blood ; Scleroderma, Systemic/pathology ; Vascular Diseases/blood ; Vascular Diseases/pathology
Czasopismo naukowe
Tytuł :
 
Autorzy :
Blaison F; Service de médecine interne et immunologie clinique, hôpital Saint-André, CHU de Bordeaux, 1 Rue Jean Burguet, 33000 Bordeaux, France. Electronic address: .
Faganello D; Service de médecine interne et immunologie clinique, hôpital Saint-André, CHU de Bordeaux, 1 Rue Jean Burguet, 33000 Bordeaux, France.
Goigoux C; Service de médecine interne et immunologie clinique, hôpital Saint-André, CHU de Bordeaux, 1 Rue Jean Burguet, 33000 Bordeaux, France.
Mercié P; Service de médecine interne et immunologie clinique, hôpital Saint-André, CHU de Bordeaux, 1 Rue Jean Burguet, 33000 Bordeaux, France.
Baulier G; Service de médecine interne et immunologie clinique, hôpital Saint-André, CHU de Bordeaux, 1 Rue Jean Burguet, 33000 Bordeaux, France.
Contin-Bordes C; Laboratoire d'immunologie et immunogénétique, hôpital Pellegrin, CHU de Bordeaux, Place Amélie Raba Léon, France.
Duffau P; Service de médecine interne et immunologie clinique, hôpital Saint-André, CHU de Bordeaux, 1 Rue Jean Burguet, 33000 Bordeaux, France.
Pokaż więcej
Transliterated Title :
Cocaïne et lésions destructrices centro-faciales : à propos d'un cas.
Źródło :
La Revue de medecine interne [Rev Med Interne] 2020 Sep; Vol. 41 (9), pp. 622-627. Date of Electronic Publication: 2020 Jul 11.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Cocaine-Related Disorders/*complications
Granulomatosis with Polyangiitis/*etiology
Nasal Septal Perforation/*etiology
Adult ; Antibodies, Antineutrophil Cytoplasmic/adverse effects ; Antibodies, Antineutrophil Cytoplasmic/blood ; Cocaine-Related Disorders/diagnosis ; Diagnosis, Differential ; Granuloma, Lethal Midline/diagnosis ; Granuloma, Lethal Midline/etiology ; Granulomatosis with Polyangiitis/diagnosis ; Humans ; Male ; Nasal Septal Perforation/diagnosis
Czasopismo naukowe
Tytuł :
[Relevance assessment of requests for antineutrophil cytoplasmic antibodies detection: Retrospective study led in Bordeaux Hospital, France].
Autorzy :
Biscay P; Service de médecine interne, hôpital de Bordeaux, hôpital Saint-André, 1, rue Jean-Burguet, 33000 Bordeaux, France. Electronic address: .
Ralazamahaleo M; Laboratoire d'immunologie et immunogénétique, hôpital de Bordeaux, 33000 Bordeaux, France.
Lazaro E; Service de médecine interne, hôpital de Bordeaux, hôpital Saint-André, 1, rue Jean-Burguet, 33000 Bordeaux, France; CNRS-UMR5164 immuno ConcEpT, université de Bordeaux, 33000 Bordeaux, France.
Richez C; CNRS-UMR5164 immuno ConcEpT, université de Bordeaux, 33000 Bordeaux, France; Service de rhumatologie, hôpital de Bordeaux, 33000 Bordeaux, France.
Seneschal J; CNRS-UMR5164 immuno ConcEpT, université de Bordeaux, 33000 Bordeaux, France; Service de dermatologie, hôpital de Bordeaux, 33000 Bordeaux, France.
Rigothier C; Service de néphrologie et transplantation rénale, hôpital de Bordeaux, 33000 Bordeaux, France; Université de Bordeaux, bio-ingénierie tissulaire, U1026, 33000 Bordeaux, France; Inserm, Bio-ingénierie tissulaire, U1026, 33000 Bordeaux, France.
Contin-Bordes C; Laboratoire d'immunologie et immunogénétique, hôpital de Bordeaux, 33000 Bordeaux, France; CNRS-UMR5164 immuno ConcEpT, université de Bordeaux, 33000 Bordeaux, France.
Duffau P; Service de médecine interne, hôpital de Bordeaux, hôpital Saint-André, 1, rue Jean-Burguet, 33000 Bordeaux, France; CNRS-UMR5164 immuno ConcEpT, université de Bordeaux, 33000 Bordeaux, France.
Pokaż więcej
Transliterated Title :
Évaluation de la pertinence des demandes d’anticorps anticytoplasme des polynucléaires neutrophiles : étude rétrospective menée au sein du centre hospitalier universitaire de Bordeaux.
Źródło :
La Revue de medecine interne [Rev Med Interne] 2017 Oct; Vol. 38 (10), pp. 656-662. Date of Electronic Publication: 2017 Jul 06.
Typ publikacji :
Evaluation Study; Journal Article
MeSH Terms :
Antibodies, Antineutrophil Cytoplasmic/*analysis
Serologic Tests/*methods
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/blood ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/diagnosis ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/economics ; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/epidemiology ; Antibodies, Antineutrophil Cytoplasmic/blood ; Cost-Benefit Analysis ; False Positive Reactions ; Fluorescent Antibody Technique, Indirect/economics ; Fluorescent Antibody Technique, Indirect/statistics & numerical data ; France/epidemiology ; Hospitals, University/statistics & numerical data ; Humans ; Intestinal Diseases/blood ; Intestinal Diseases/diagnosis ; Intestinal Diseases/epidemiology ; Intestinal Diseases/etiology ; Predictive Value of Tests ; Retrospective Studies ; Serologic Tests/economics ; Serologic Tests/statistics & numerical data
Czasopismo naukowe
Tytuł :
Prevalence of IgA Antibodies to β2-Glycoprotein I: A Population-Dependent Feature?
Autorzy :
Visentin J; 1 Laboratoire d'Immunologie et Immunogénétique, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France. 2 UMR CNRS 5164, Université de Bordeaux, Bordeaux, France. 3 Laboratoire d'Hématologie, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France. 4 Service de Néphrologie, Transplantation, Dialyse, Hôpital Pellegrin, CHU de Bordeaux, Bordeaux, France.
Ramaharo D
Ryman A
Contin-Bordes C
Merville P
Pokaż więcej
Źródło :
Transplantation [Transplantation] 2016 Mar; Vol. 100 (3), pp. e13-4.
Typ publikacji :
Journal Article
MeSH Terms :
Autoantibodies/*blood
Graft Rejection/*immunology
Immunoglobulin A/*blood
Kidney Failure, Chronic/*surgery
Kidney Transplantation/*adverse effects
beta 2-Glycoprotein I/*immunology
Adult ; Aged ; Cohort Studies ; Enzyme-Linked Immunosorbent Assay ; Female ; Graft Rejection/blood ; Graft Rejection/diagnosis ; Graft Survival ; Humans ; Kidney Failure, Chronic/blood ; Kidney Failure, Chronic/immunology ; Male ; Middle Aged ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
OX40 Ligand Contributes to Human Lupus Pathogenesis by Promoting T Follicular Helper Response.
Autorzy :
Jacquemin C; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France.
Schmitt N; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Contin-Bordes C; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Liu Y; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Narayanan P; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Seneschal J; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Maurouard T; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Dougall D; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Davizon ES; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Dumortier H; CNRS, Immunopathology and therapeutic chemistry/Laboratory of excellence MEDALIS, Institut de Biologie Moléculaire et Cellulaire;University of Strasbourg, F-67081 Strasbourg, France.
Douchet I; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France.
Raffray L; CHU de Bordeaux, F-33076 Bordeaux, France.
Richez C; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Lazaro E; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Duffau P; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Truchetet ME; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Khoryati L; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France.
Mercié P; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Couzi L; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Merville P; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Schaeverbeke T; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Viallard JF; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Pellegrin JL; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Moreau JF; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; CHU de Bordeaux, F-33076 Bordeaux, France.
Muller S; CNRS, Immunopathology and therapeutic chemistry/Laboratory of excellence MEDALIS, Institut de Biologie Moléculaire et Cellulaire;University of Strasbourg, F-67081 Strasbourg, France; University of Strasbourg Institute for Advanced Study, F-67081 Strasbourg, France.
Zurawski S; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Coffman RL; Dynavax Technologies Corporation, Berkeley, CA 94710, USA.
Pascual V; Baylor Institute for Immunology Research, Dallas, TX 75204, USA.
Ueno H; Baylor Institute for Immunology Research, Dallas, TX 75204, USA. Electronic address: .
Blanco P; University Bordeaux, CIRID, UMR/CNRS 5164, F-33000 Bordeaux, France; CNRS, CIRID, UMR 5164, F-33000 Bordeaux, France; Baylor Institute for Immunology Research, Dallas, TX 75204, USA; CHU de Bordeaux, F-33076 Bordeaux, France. Electronic address: .
Pokaż więcej
Źródło :
Immunity [Immunity] 2015 Jun 16; Vol. 42 (6), pp. 1159-70. Date of Electronic Publication: 2015 Jun 09.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Lupus Erythematosus, Systemic/*immunology
Myeloid Cells/*immunology
OX40 Ligand/*metabolism
Receptors, OX40/*metabolism
T-Lymphocytes, Helper-Inducer/*immunology
Adolescent ; Adult ; Aged ; Antigen Presentation ; B-Lymphocytes/immunology ; Cell Differentiation ; Cells, Cultured ; Cytokines/metabolism ; Disease Progression ; Female ; Humans ; Immunologic Memory ; Inducible T-Cell Co-Stimulator Protein/metabolism ; Lymphocyte Activation ; Male ; Middle Aged ; Molecular Targeted Therapy ; RNA/immunology ; Signal Transduction ; Toll-Like Receptor 7/metabolism ; Young Adult
Czasopismo naukowe
    Wyświetlanie 1-65 z 65

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies